Titan Medical Inc.
TMDI · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $10 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $10 |
| % Margin | – | – | – | 100% |
| R&D Expenses | $8 | $10 | $9 | $11 |
| G&A Expenses | $3 | $3 | $3 | $2 |
| SG&A Expenses | $3 | $3 | $3 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $11 | $13 | $12 | $13 |
| Operating Income | -$10 | -$11 | -$9 | $9 |
| % Margin | – | – | – | 94.3% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$10 | -$11 | -$9 | $9 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10 | -$11 | -$9 | $9 |
| % Margin | – | – | – | 94.3% |
| EPS | -0.093 | -0.098 | -0.083 | 0.085 |
| % Growth | 4.8% | -17.8% | -197.9% | – |
| EPS Diluted | -0.093 | -0.098 | -0.083 | 0.085 |
| Weighted Avg Shares Out | 112 | 111 | 111 | 111 |
| Weighted Avg Shares Out Dil | 112 | 111 | 111 | 111 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$10 | -$11 | -$9 | $10 |
| % Margin | – | – | – | 97.3% |